Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Production / Operations Routine +

Herbal Dispatch Reports Accelerating Veteran Customer Growth and Expansion of Insurance-Focused Service Channel

Veteran Channel Momentum Validates Strategy, But Profitability Remains Elusive

Executive Summary
  • The most recent release (May 7, 2026) details accelerating growth in the veteran-focused medical cannabis channel.
  • Q1 2026 veteran registrations increased by approximately 400% compared to the full year of 2025.
  • Annualized revenue run rate for this segment escalated from $675,000 (2025) to ~$2.23 million as of April 2026.
  • Gross margins on the veteran segment are reported at 50%+, significantly higher than the company's overall gross margin of 22.7% in FY 2025.
  • Q2 2026 estimated gross sales for this channel are projected at ~$850,000 (Annualized $3.5M - $4M).
  • This update follows the May 5, 2026 launch of an upgraded e-commerce platform targeting the insured medical cannabis segment.
Material Impact
  • Validation of Strategy: The news confirms execution on the "Strategic Business Plan for 2026" released in December 2025, which targeted a 200% annual increase in veteran sales. The reported 400% registration growth exceeds this target.
  • Margin Profile Improvement: The shift toward high-margin (50%+) insured/veteran revenue is positive for long-term profitability, contrasting with the company's overall FY 2025 gross margin of only 22.7%.
  • Revenue Scale Limitation: While growth rates are high, the absolute dollar value ($2.23M run rate) remains small relative to total FY 2025 gross sales of $16.5 million. It does not yet materially alter the company's overall financial trajectory or loss position.
  • Consistency with History: This news is consistent with previous operational updates (April 30 export success, April 24 earnings showing positive Q4 EBITDA). It represents incremental progress rather than a fundamental shift in business model.
  • Risk Note: The company reported a net loss of $1.84 million for 2025 despite sales growth. High operating costs and debt interest (14% on convertible debentures) continue to erode bottom-line performance.
HERB · Price
Company Overview
  • Overview: Herbal Dispatch Inc. operates as a cannabis distributor and service provider in Canada with growing international export operations. It focuses on medical cannabis channels (veterans, insured patients) and recreational wholesale.
  • Flagship Project: The "HeroDispatch" platform targeting the insured medical cannabis segment, specifically veterans. This channel offers recurring revenue and higher margins compared to standard recreational sales.
  • International Footprint: Active export relationships in Australia, Portugal, Germany, Brazil, Czech Republic, UK, Switzerland, and Costa Rica. Recent milestones include a 298kg shipment to Germany (Jan 2026) and $350k gummy export to Australia (Apr 2026).
  • Brands: Owns "Chomp Edibles" brand launched in April 2026, targeting the accessible premium category.
Read the original news release →

More from Herbal Dispatch Inc.